Editorial Staff

Editorial Staff

NewsWriter.ai

@editorial-staff

Newswriter.ai is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.

23607 articles
Maximize your thought leadership

Articles

Keona Health Introduces Rule of ONE Framework to Standardize Healthcare Call Center Operations

Keona Health Introduces Rule of ONE Framework to Standardize Healthcare Call Center Operations

Keona Health's new analysis outlines the Rule of ONE framework, aiming to reduce inefficiencies in healthcare call centers by centralizing workflows and standardizing call handling processes.
LIG Assets Advances SK-1300 Valuation for Marianna Calcium Mine, Targeting Updated Reserve Estimates

LIG Assets Advances SK-1300 Valuation for Marianna Calcium Mine, Targeting Updated Reserve Estimates

LIG Assets, Inc. is working on a modern SK-1300 technical report to validate and potentially increase the valuation of its calcium carbonate mining assets in Marianna, Florida, which were previously appraised at $400 million.
HR.com Awards Recognize AI and HR Tech Innovations Driving Workforce Transformation

HR.com Awards Recognize AI and HR Tech Innovations Driving Workforce Transformation

HR.com announced the winners of the 2026 HR Tech Innovation & Implementation Awards, highlighting Harbinger Group's AI-powered performance management tool POLESTAR and Willow Bridge Property Company's HRIS modernization as transformative solutions.
SureNano Science's GLP-1 Innovation Targets Improved Obesity and Diabetes Treatments

SureNano Science's GLP-1 Innovation Targets Improved Obesity and Diabetes Treatments

SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is developing GEP-44, a novel triple agonist peptide for obesity and type 2 diabetes, aiming to enhance efficacy, tolerability, and delivery flexibility in the expanding GLP-1 market.
BluSky AI Launches Regulation A+ Offering for AI Infrastructure Expansion

BluSky AI Launches Regulation A+ Offering for AI Infrastructure Expansion

BluSky AI Inc. has launched a Regulation A+ offering to raise capital for expanding its distributed AI infrastructure network, allowing individual investors to participate with a minimum investment of $1,000.
American Fusion Highlights Strategic Washington Engagements and Corporate Progress

American Fusion Highlights Strategic Washington Engagements and Corporate Progress

American Fusion Inc. provided an update on its strategic discussions in Washington, D.C., regarding its Texatron Fusion Engine platform, and outlined corporate advancements including Form 10 effectiveness and OTCQB qualification.
NextPlat Corp Reports Improved Q1 2026 Results, Nears Profitability Amid Turnaround

NextPlat Corp Reports Improved Q1 2026 Results, Nears Profitability Amid Turnaround

NextPlat Corp announced first-quarter 2026 results showing a record gross margin and reduced net loss, positioning the company to achieve positive operating income in the second half of the year.
Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance

Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance

Aditxt Inc. will implement a 1-for-27 reverse stock split effective May 18, 2026, to meet Nasdaq's minimum bid price requirement, reducing outstanding shares from 13.8 million to approximately 510,123.
Oncotelic Therapeutics Highlights Intranasal Drug Delivery Platform for CNS Disorders in BioMedWire Editorial

Oncotelic Therapeutics Highlights Intranasal Drug Delivery Platform for CNS Disorders in BioMedWire Editorial

Oncotelic Therapeutics announces its featured placement in a BioMedWire editorial discussing its intranasal nose-to-brain delivery platform, which aims to overcome the blood-brain barrier for treating Alzheimer's disease and biodefense applications.
SPARC AI Featured in Editorial on Autonomous Warfare Technologies, Highlighting GPS-Denied Navigation Solution

SPARC AI Featured in Editorial on Autonomous Warfare Technologies, Highlighting GPS-Denied Navigation Solution

SPARC AI Inc. was featured in an AINewsWire editorial discussing its software-only platform for GPS-denied drone navigation and targeting, addressing critical defense needs in contested electronic warfare environments.
Duck Key Dining Scene Emerges as Key Factor for Luxury Real Estate Buyers

Duck Key Dining Scene Emerges as Key Factor for Luxury Real Estate Buyers

The Brenner Scheel & Casey Team highlights how the exceptional restaurant and seafood scene in the Middle Keys influences high-end home purchases on Duck Key.
Microsoft May Abandon Clean Energy Goals as AI Power Demands Surge

Microsoft May Abandon Clean Energy Goals as AI Power Demands Surge

Microsoft is considering delaying or scrapping its ambitious 2030 clean energy goal due to rising power consumption from AI, highlighting tensions between tech growth and sustainability.
Extend your brand profile by curating daily news.
China to Implement Regulations for EV Battery Recycling Amid Safety and Environmental Concerns

China to Implement Regulations for EV Battery Recycling Amid Safety and Environmental Concerns

Chinese authorities are introducing new rules to formalize electric vehicle battery recycling, aiming to curb the dominance of informal operations that currently handle about 70% of retired batteries, posing safety and environmental risks.
NIH-Funded Study Links Low Testosterone to Shorter Survival in Men with Glioblastoma

NIH-Funded Study Links Low Testosterone to Shorter Survival in Men with Glioblastoma

New research funded by the NIH indicates that men with low testosterone levels may have shorter survival times when diagnosed with glioblastoma, a finding that could impact treatment strategies and drug development for companies like CNS Pharmaceuticals.
Alphabet to Issue Yen-Denominated Bonds to Finance AI Investments

Alphabet to Issue Yen-Denominated Bonds to Finance AI Investments

Alphabet is planning to offer yen-denominated bonds to fund its growing AI investments, reflecting a trend among major tech companies to tap overseas debt markets for AI-related costs.
MindBio Therapeutics Develops AI-Powered Voice Analysis for Real-Time Intoxication Detection

MindBio Therapeutics Develops AI-Powered Voice Analysis for Real-Time Intoxication Detection

MindBio Therapeutics is advancing an AI-driven voice analysis platform to detect drug and alcohol intoxication from brief speech recordings, targeting healthcare, workplace safety, and public health applications.
Clarity Act Progress Fuels Optimism in Crypto Markets

Clarity Act Progress Fuels Optimism in Crypto Markets

Crypto asset investment products saw nearly $860 million in inflows last week, marking six consecutive weeks of positive flows driven by optimism over proposed U.S. regulation, with implications for market sentiment and industry growth.
Proposed Relaxation of AI Healthcare Safeguards Draws Mixed Reactions

Proposed Relaxation of AI Healthcare Safeguards Draws Mixed Reactions

The Department of Health and Human Services plans to ease safeguards for AI tools in healthcare, sparking debate over regulation and testing requirements.
Strait of Hormuz Disruption Threatens EV Battery Supply Chains

Strait of Hormuz Disruption Threatens EV Battery Supply Chains

The ongoing crisis in the Strait of Hormuz is endangering the global electric vehicle industry by hindering transport of critical raw materials for EV batteries, potentially causing supply shortages and higher costs.
SureNano Science's GEP-44 Triple Agonist Peptide Targets Next-Gen GLP-1 Market

SureNano Science's GEP-44 Triple Agonist Peptide Targets Next-Gen GLP-1 Market

SureNano Science Ltd. is featured in a BioMedWire editorial highlighting its subsidiary GlucaPharm's GEP-44, a triple agonist peptide aiming to improve obesity and diabetes treatment with better tolerability and non-injectable delivery options.
CNS Pharmaceuticals Reports Q1 2026 Results, Advances Strategic Pivot to Acquisition-Driven Growth

CNS Pharmaceuticals Reports Q1 2026 Results, Advances Strategic Pivot to Acquisition-Driven Growth

CNS Pharmaceuticals reported first-quarter 2026 financial results and detailed its shift to an acquisition-driven model in neurology and oncology, bolstered by a $22.5 million private placement expected to fund operations beyond 12 months.

Showing 6280-6300 of 23607 articles (Page 300 of 1125)